| SPRY Stock | | | 12.57 0.39 3.20% |
Silverback Therapeutics financial indicator trend analysis is much more than just breaking down Silverback Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Silverback Therapeutics is a good investment. Please check the relationship between Silverback Therapeutics Total Liab and its Accounts Payable accounts. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Silverback Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Silverback Stock please use our
How to Invest in Silverback Therapeutics guide.
Total Liab vs Accounts Payable
Total Liab vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Silverback Therapeutics Total Liab account and
Accounts Payable. At this time, the significance of the direction appears to have no relationship.
The correlation between Silverback Therapeutics' Total Liab and Accounts Payable is 0.09. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Silverback Therapeutics, assuming nothing else is changed. The correlation between historical values of Silverback Therapeutics' Total Liab and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Silverback Therapeutics are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Total Liab i.e., Silverback Therapeutics' Total Liab and Accounts Payable go up and down completely randomly.
Correlation Coefficient | 0.09 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.
Accounts Payable
An accounting item on the balance sheet that represents Silverback Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Silverback Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Silverback Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Silverback Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Silverback Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Silverback Stock please use our
How to Invest in Silverback Therapeutics guide.At this time, Silverback Therapeutics'
Selling General Administrative is fairly stable compared to the past year.
Sales General And Administrative To Revenue is likely to rise to 1,489 in 2025, whereas
Enterprise Value Over EBITDA is likely to drop
(6.32) in 2025.
Silverback Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Silverback Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Silverback Therapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Silverback Stock Analysis
When running Silverback Therapeutics' price analysis, check to
measure Silverback Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Silverback Therapeutics is operating at the current time. Most of Silverback Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Silverback Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Silverback Therapeutics' price. Additionally, you may evaluate how the addition of Silverback Therapeutics to your portfolios can decrease your overall portfolio volatility.